157 related articles for article (PubMed ID: 12544837)
1. DC11: a novel monoclonal antibody revealing Alzheimer's disease-specific tau epitope.
Vechterova L; Kontsekova E; Zilka N; Ferencik M; Ravid R; Novak M
Neuroreport; 2003 Jan; 14(1):87-91. PubMed ID: 12544837
[TBL] [Abstract][Full Text] [Related]
2. Tau-66: evidence for a novel tau conformation in Alzheimer's disease.
Ghoshal N; García-Sierra F; Fu Y; Beckett LA; Mufson EJ; Kuret J; Berry RW; Binder LI
J Neurochem; 2001 Jun; 77(5):1372-85. PubMed ID: 11389188
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
Kondratick CM; Vandré DD
J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
[TBL] [Abstract][Full Text] [Related]
4. Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
Horowitz PM; Patterson KR; Guillozet-Bongaarts AL; Reynolds MR; Carroll CA; Weintraub ST; Bennett DA; Cryns VL; Berry RW; Binder LI
J Neurosci; 2004 Sep; 24(36):7895-902. PubMed ID: 15356202
[TBL] [Abstract][Full Text] [Related]
5. Conformational change as one of the earliest alterations of tau in Alzheimer's disease.
Weaver CL; Espinoza M; Kress Y; Davies P
Neurobiol Aging; 2000; 21(5):719-27. PubMed ID: 11016541
[TBL] [Abstract][Full Text] [Related]
6. The N terminal region of human tau is present in Alzheimer's disease protein A68 and is incorporated into paired helical filaments.
Crowe A; Ksiezak-Reding H; Liu WK; Dickson DW; Yen SH
Am J Pathol; 1991 Dec; 139(6):1463-70. PubMed ID: 1721492
[TBL] [Abstract][Full Text] [Related]
7. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease.
Jicha GA; Lane E; Vincent I; Otvos L; Hoffmann R; Davies P
J Neurochem; 1997 Nov; 69(5):2087-95. PubMed ID: 9349554
[TBL] [Abstract][Full Text] [Related]
8. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.
Jicha GA; Bowser R; Kazam IG; Davies P
J Neurosci Res; 1997 Apr; 48(2):128-32. PubMed ID: 9130141
[TBL] [Abstract][Full Text] [Related]
9. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.
Luna-Muñoz J; García-Sierra F; Falcón V; Menéndez I; Chávez-Macías L; Mena R
J Alzheimers Dis; 2005 Sep; 8(1):29-41. PubMed ID: 16155347
[TBL] [Abstract][Full Text] [Related]
10. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
[TBL] [Abstract][Full Text] [Related]
11. A Phosphorylation-Induced Turn Defines the Alzheimer's Disease AT8 Antibody Epitope on the Tau Protein.
Gandhi NS; Landrieu I; Byrne C; Kukic P; Amniai L; Cantrelle FX; Wieruszeski JM; Mancera RL; Jacquot Y; Lippens G
Angew Chem Int Ed Engl; 2015 Jun; 54(23):6819-23. PubMed ID: 25881502
[TBL] [Abstract][Full Text] [Related]
12. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology.
Carmel G; Mager EM; Binder LI; Kuret J
J Biol Chem; 1996 Dec; 271(51):32789-95. PubMed ID: 8955115
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein: identification of hidden and cleaved tau epitopes and a new phosphorylation site.
Dickson DW; Ksiezak-Reding H; Liu WK; Davies P; Crowe A; Yen SH
Acta Neuropathol; 1992; 84(6):596-605. PubMed ID: 1281953
[TBL] [Abstract][Full Text] [Related]
14. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
Combs B; Hamel C; Kanaan NM
Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
[TBL] [Abstract][Full Text] [Related]
15. A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.
Brici D; Götz J; Nisbet RM
J Alzheimers Dis; 2018; 61(3):899-905. PubMed ID: 29332046
[TBL] [Abstract][Full Text] [Related]
16. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease.
Brion JP; Couck AM; Robertson J; Loviny TL; Anderton BH
J Neurochem; 1993 Apr; 60(4):1372-82. PubMed ID: 7681101
[TBL] [Abstract][Full Text] [Related]
17. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
18. Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer's disease.
Singer D; Lehmann J; Hanisch K; Härtig W; Hoffmann R
Biochem Biophys Res Commun; 2006 Aug; 346(3):819-28. PubMed ID: 16781671
[TBL] [Abstract][Full Text] [Related]
19. A tau-related protein of 130 kDa is present in Alzheimer brain.
Gache Y; Guilleminot J; Ricolfi F; Theiss G; Nunez J
J Neurochem; 1992 Jun; 58(6):2005-10. PubMed ID: 1374115
[TBL] [Abstract][Full Text] [Related]
20. Transition of tau protein from disordered to misordered in Alzheimer's disease.
Kovacech B; Skrabana R; Novak M
Neurodegener Dis; 2010; 7(1-3):24-7. PubMed ID: 20160453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
